Drug Search Results
More Filters [+]

HU-014

Alternative Names: hu-014, hu014, hu 014
Latest Update: 2023-08-01
Latest Update Note: Clinical Trial Update

Product Description

Clostridium botulinum type A

Mechanisms of Action: AChR Blocker

Novel Mechanism: Yes

Modality: N/A

Route of Administration: Injection

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Huons
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for HU-014

Countries in Clinic: Korea

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Muscle Spasticity|Stroke

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

HU-014

P3

Completed

Muscle Spasticity|Stroke

2023-01-03

Recent News Events